Professor Charles Flexner – DDI's and DAA's: How Drug Interactions Continue to Vex HCV Treatment

Event type: 
Event date: 
Tuesday, 28 February 2017 - 1:00pm to 2:00pm

Berg Family Foundation Seminar Room, Level 6, Wallace Wurth Building, UNSW Australia, Sydney

Contact for inquiries: 
Rata Joseph, +61 (2) 9385 0900 or
Booking deadline: 


Professor of Medicine, Pharmacology and Molecular Sciences, and International Health, Johns Hopkins University
Deputy Director, Institute for Clinical and Translational Research


About your speaker

Charles Flexner, MD, is a recognised expert on the basic and clinical pharmacology of drugs for HIV, HCV, and related infections. He is currently the Co-PI of the Baltimore-Washington-India AIDS Clinical Trials Unit (BWI CTU), and is Director of the Long-Acting/Extended Release Antiretroviral Resource Program (LEAP; He is the Past President of the American Federation for Medical Research, and has chaired the Pharmacology and Translational Research and Drug Development Committees of the AIDS Clinical Trials Group (ACTG) of NIH.